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1  | BACKGROUND
Stroke is one of the leading causes for morbidity, disability and death 
worldwide. The risk of recurrent stroke is 12%-13% within the first 
year of the index stroke and 4%-5% in the following year.1 Recurrent 
stroke is an independent risk factor for loss of function, institutional-
ization and death.2 Secondary and tertiary prevention are therefore 
important parts of stroke management.
The pathological mechanisms behind vascular diseases are 
complex. It is evident that hypertension and other modifiable risk 
factors, such as smoking, physical inactivity, unhealthy diet and ab-
dominal obesity, are all contributors to the risk of both ischaemic and 
haemorrhagic stroke.3,4
Improved health behaviour is therefore widely recommended as 
part of the secondary prevention,5 yet our knowledge as to how these 
recommendations are applied effectively in clinical practice is sparse.
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Introduction: Improvements in health behaviour are often recommended as part 
of secondary prevention in patients with stroke and transient ischaemic attack. 
However, there is a lack of knowledge as to how this is applied in clinical practice.
Aim: In this systematic review and meta-analysis, we examined the effect of coun-
selling or educational intervention directed at individual or multiple behavioural risk 
factors on blood pressure and other reported outcomes.
Methods: PubMed, Embase, PsycInfo, CINAHL, Scopus and Web of Science were 
systematically searched. Meta-analyses were conducted on all outcome measures if 
appropriate. A qualitative analysis of the content of the interventions was conducted 
to review which elements the interventions consisted of.
Results: Twenty-nine randomized controlled trials were identified. Fourteen reported 
effects on systolic blood pressure, and pooled results showed a significant beneficial 
effect (n = 2,222; −3.85 mmHg [95%CI −6.43; −1.28]). The effect was greatest in the 
four interventions which included supervised training (n = 174; −9.83 mmHg [95%CI 
−16.56; −3.09]).
Conclusion: Modifying health behaviour in stroke survivors might have a moderate 
beneficial effect on blood pressure, especially if the intervention includes supervised 
physical training.
K E Y W O R D S
adherence, exercise, health behaviour, health counselling, physical activity, smoking, stroke, 
transient ischaemic attack
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The results of previous systematic reviews have been inconsis-
tent. In a meta-analysis of 42 randomized controlled trials (RCT) of 
stroke service-based secondary prevention interventions, Bridgwood 
et al6 found no significant difference in any outcome measures, al-
though there was a tendency towards a greater effect of organiza-
tional changes compared to educational/behavioural interventions. In 
a meta-analysis of 20 RCTs of multi-modal behavioural interventions, 
Lawrence et al7 found a significant effect on systolic and diastolic blood 
pressure, waist circumference, but not on blood lipids, blood glucose, 
body composition, smoking or fruit/vegetable consumption. In a me-
ta-analysis of 22 RCTs of lifestyle interventions in patients with stroke 
or transient ischaemic attacks (TIA), Deijle et al8 found a significant 
effect on systolic blood pressure, but not on diastolic blood pressure, 
cardiovascular events or blood lipids. A greater effect on systolic blood 
pressure was found in interventions which included aerobic exercise 
training and with a duration > 4 months.
Most behavioural interventions are multi-modal and complex. 
The varying results in previous studies might imply that some el-
ements contribute more to the effect than others. We therefore 
need to examine the content of the interventions in order to iden-
tify the most effective approaches to behavioural change after 
stroke or TIA.
2  | OBJEC TIVES
The primary objective was to examine the effect of single- or multi-
modal counselling or educational intervention directed at individual 
F I G U R E  1   Search strategy and selection of reports
Database 
searches:
10052
5967 records aer 
duplicates are removed
4993 tles screened
827 abstracts assessed 
for eligibility
29 studies included in 
qualitave synthesis
22 studies included in 
meta-analysis
129 full-text arcles 
assessed for eligibility
Other publicaon types
(secondary publicaons)
- 825 reviews
- 149 other types (books, 
guidelines, leers, etc.)
698 records excluded based on 
abstracts:
- Study populaon not relevant 
(n=121)
- Intervenon not relevant (n=287) 
- Non-randomized design (n=276)
- Outcomes not relevant (n=14)
4166 records excluded based on tle:
- Study populaon not relevant 
(n=1615)
- Intervenon not relevant (n=2217)
- Non-randomized study design 
(n=334)
References from 
previous systemac 
reviews:
42
100 full-text arcles excluded:
- Study reported in other included 
records (n=31)
- Records without results; study 
protocols (n=12) 
- Study populaon not relevant
(n=10)
- Intervenon not relevant (n=27)
- Non-randomized design (n=7)
- Outcomes not relevant (n=10)
- Methodological issues/ 
insufficient reporng (n=3)
Databases searched 
MedLine (2134 records), EMBASE 1974-2017 (3279 records), 
CINAHL (460 records), PsycInfo (260 records), Scopus (2304 
records), Web of Science (1615 records)
Search terms
Populaon
Stroke, cerebrovascular disease, apoplexy, CVA, cerebral 
hemorrhage, cerebral infarct, cerebral ischemia, vascular 
accident, transient ischemic aack, cerebral ischemia transient, 
TIA, “cerebral small vessel disease”
Outcomes
Epidemiological outcomes
Recurren*, survival, mortality, death, fatality
Physiological outcomes
Blood pressure, vital signs, hypertension, lipids, cholesterol, 
triglycerides, dyslipidemia, “lipid metabolism disorder”, 
exercise, fitness, physical acvity, exercise therapy, physical 
fitness, smoking, smoking cessaon, tobacco use, tobacco, 
tobacco products, diet, eang, food, salt intake, sodium, 
anthropometry, body constuon, BMI, body mass index, body 
size, weight, waist, diabetes, blood sugar, blood glucose, 
hyperglycemia, insulin, insulin resistance, insulin sensivity, 
HbA1c, metabolic syndrome, alcohol, drinking, drinking  
behavior, alcohol-related disorder
Paent reported outcomes
Depression, mood, affecve, anxiety, quality of life, stress, 
paent reported outcome
Exposures/behaviour
Smoking, tobacco, tobacco use, tobacco products, exercise, 
fitness, physical acvity, exercise therapy, physical fitness, 
complian*, persisten*, adheren*, non-complian*, non-
persisten*, non-adheren*, “paent compliance”, life style, 
lifestyle, health behavio*
Study design
Randomized controlled trial, RCT
Excluded
Surgical, surgery, operave, stent, ablaon, endarterectomy, 
guideline, cardioversion, foramen ovale, electrical, placebo
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TA B L E  1   Characteristics of the study participants
Number of participants
Study (Country) Screened Eligible Randomized Completed Age (y)
Female 
(%)
Included 
diagnoses
Primary inclusion 
criteria
Adie 2010 (UK)36 NA NA 56 56 72.5 ± 8.9 50% TIA (43%)/minor 
stroke (57%)
Age ≥ 18 y, 
hypertension, 
living at home
Allen 2002 (USA)20 417 238 93 73 70.5 ± 11.0 56% IS (70.5%), TIA 
(29.5%)
Admitted from 
home, Rankin 
scale ≤ 3
Allen 2009 (USA)37 NA NA 380 319 65 ± 14.3 50% IS (NIHSS ≥ 1) Discharge to home
Barker-Collo 2015 
(NZ)21
3487 NA 386 331 NA NA Stroke (not 
specified)
Age ≥ 16 y
Boss 2014 (NL)38 NA NA 20 18 63 y (range 
46-78)
30% TIA (40%), minor 
stroke (60%) 
(NIHSS < 4)
Age ≥ 18 y, 
able to walk 
independently
Boysen 2009 (DK)39 2000 NA 314 276 69.7 y (IQR 
60-78)
44% IS Age ≥ 40 y, able to 
walk unassisted
Brunner Frandsen 
2012 (DK)40
NA NA 94 88 53% 
50-65 y/ 
26% >65 y
42% IS & TIA Age < 76 y, current 
daily smoker
Chanruengvanich 
2006 (TH)41
NA NA 72 62 63 ± 7.2 68% TIA & minor 
stroke
Age > 45 y, able to 
exercise safely
Cheng 2018 (USA)22 1476 NA 404 404 57.4 y 40% IS & TIA SBP ≥ 120 mmHg, 
English or 
Spanish speaker
Damush 2011 (USA)23 1017 NA 63 63 65.6 ± 10.5 2% IS Age ≥ 18 y, English 
speaker
English 2016 (AU)42 NA 72 33 33 67.3 ± 13.0 33% IS (76%) & ICH 
(24%)
Living at home
Evans-Hudnall 2014 
(USA)43
210 NA 60 52 53.0 ± 10.7 39% IS & TIA Age ≥ 18 y, 
discharged home
Faulkner 2014 (NZ)24 167 97 60 51 68.5 ± 10.4 48% TIA/minor stroke First ever TIA/
stroke
Flemming 2013 
(USA)44
1083 110 41 36 71 ± 11.0 41% Atherosclerotic 
IS (54%) & TIA 
(46%)
Age ≥ 55 y, at least 
one uncontrolled 
risk factor
Gillham 2010 (UK)25 91 NA 52 50 68.3 ± 12.5 NA First time IS & TIA First time stroke/
TIA
Holzemer 2011 
(USA)45
274 NA 52 27 62.4 ± 12.0 NA IS & TIA Age ≥ 18 y
Hornnes 2009 (DK)26 917 470 349 303 69.3 ± 12.9 49% IS, ICH, TIA Relevant diagnosis
Irewall 2015 (SE)27 1102 NA 537 484 70.8 ± 10.8 43% IS (60%), ICH (4%), 
TIA (37%)
Able to participate
Joubert 2006 (AU)28 421 224 97 80 66.5 ± 13.7 50% IS, ICH, TIA Age ≥ 20 y, 
discharged to GP 
management
Joubert 2009 (AU)46 NA NA 233 186 65.9 ± 13.4 45% IS, ICH, TIA Age ≥ 20 y, 
discharged to GP 
management
Kim 2013 (KR)29 278 NA 36 34 65.7 ± 7.5 36% IS Living at home, 
access to the 
internet
(Continues)
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or multiple lifestyle risk factors on blood pressure and hypertension 
in patients with stroke or TIA.
The secondary objectives were to examine the effects on other 
outcomes, including recurrence of stroke and TIA, biochemistry, and 
health behaviour, and to examine the content and methodology of 
previous interventional studies.
3  | METHODS
A systematic review of RCTs of counselling and educational inter-
ventions with stroke patients was conducted in accordance with the 
PRISMA statement.9
3.1 | Search method and eligibility criteria
Database searches were made in PubMed, Embase, PsycInfo, 
CINAHL, Scopus and Web of Science (see Figure 1); citations in 
previous articles were screened for relevant references. The search 
strategy was designed in collaboration with an experienced research 
librarian. Studies were included if they were RCTs of counselling or 
educational interventions (individual or group) targeting single or 
multiple lifestyle risk factors in hospital, outpatient or community 
settings, including adult (≥18 years) patients with first or recurrent 
stroke or TIA. The primary outcome of interest was systolic blood 
pressure; secondary outcomes included stroke recurrence, vascu-
lar events, mortality, physiological outcomes (eg blood pressure, 
blood lipids, body composition), health behaviour (eg smoking hab-
its, alcohol consumption, diet, physical activity) or patient-reported 
outcomes.
Studies were excluded if they were not randomized and if the 
intervention was a pharmacological treatment (eg nicotine replace-
ment) or focused on neurological rehabilitation of physical function 
or everyday activity.
Titles were screened, and duplicates and non-original publica-
tions (reviews, editorials, guidelines etc) were excluded by JL. Titles 
and abstracts were assessed by JL in the remaining references ex-
cluding studies that clearly included patients without cerebrovascu-
lar diseases, if the intervention was not relevant, if the design was 
Number of participants
Study (Country) Screened Eligible Randomized Completed Age (y)
Female 
(%)
Included 
diagnoses
Primary inclusion 
criteria
Kirk 2014 (UK)30 70 NA 24 24 67.2 ± 9.4 21% Minor stroke 
(25%), TIA (75%)
Fit for exercise
Kono 2013 (JP)31 159 134 70 68 63.5 ± 9.4 31% Minor stroke (non-
cardioembolic)
Discharged home, 
mRS 0-1
McManus 2009 
(UK)47
1804 NA 205 102 65.1 ± 9.3 48% Stroke (63%), TIA 
(27%), amaurosis 
fugax (4%), TGA 
(1%), RAO (2%), 
MID (3%)
At least one 
relevant risk 
factor
Moren 2016 (SE)32 127 NA 88 56 71.1 ± 8.7 53% TIA Medically 
stable, able to 
communicate in 
Swedish
Nir 2004 (IL)48 NA NA 155 NA 73.1 ± 7.3 48% Stroke (not 
specified)
Relevant diagnosis
Peng 2014 (CN)49 NA NA 3821 3330 60.9 ± 11.6 32% IS & TIA Age ≥ 18 y, 
clinically stable, 
habitually 
independent in 
ADL
Wan 2016 (CN)33 186 103 91 80 59.7 ± 12.4 29% IS Age > 35 y, 
habitually 
independent in 
ADL
Wolfe 2010 (UK)34 941 NA 523 487 21% >80 y 47% IS (85.7%) Registered with a 
study GP
Abbreviations: ADL, Activity of Daily Living; GP, General practitioner; ICH, Intracerebral haemorrhage; IS, Ischaemic stroke; MID, Multi-Infarct 
Disease; mRS, Modified Rankin Scale; NIHSS, NIH Stroke Scale; RAO, Retinal Artery Occlusion; TIA, Transient Ischaemic Attacks.
TA B L E  1   (Continued)
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non-randomized, or no relevant outcomes were reported. In case 
information in the abstract was insufficient for exclusion the full text 
article was assessed. Full-text assessment was performed by three 
reviewers independently (JL, MML, TM), and discrepancies were dis-
cussed until consensus was achieved.
Data extraction was done by two reviewers independently using 
a standardized extraction form. Extracted data included details of the 
study design, population, intervention (timing, setting, procedures, dos-
age, mode of delivery), comparator intervention and relevant outcomes.
Methodological quality and risk of bias were assessed by two re-
viewers independently using the Cochrane Risk of Bias tool (RoB),10 
and discrepancies were resolved by discussion. If agreement was not 
meet, a third reviewer was consulted.
3.2 | Qualitative analysis of the content of the 
intervention
A qualitative analysis of the reported interventions was conducted 
with the aim of gaining an overview of how the interventions at-
tempted to modify the behaviour of the participants. Relevant parts 
of the articles, explaining the procedures of the interventions, were 
evaluated line by line and coded with explanatory expressions. 
Summaries of the interventions were constructed based on the codes, 
simple enough to give an overview but with enough details to be loyal 
to the original reports. The summaries were used to identify the main 
elements of the approaches and the targets of the intervention.
Each element of the intervention was categorized using the 
World Health Organization's ICF-model as a framework, categoriz-
ing the elements according to body function & anatomy, activity, par-
ticipation, personal factors and environmental factors.
3.3 | Quantitative meta-analyses
Meta-analyses were performed to estimate the overall treatment 
effect on all outcome measures reported in a comparable manner 
in at least two studies using Review Manager 5.3.11 As a result of 
variance in study populations, we used random effects models in 
all meta-analyses.12 For continuous variables, we used mean dif-
ferences if all studies reported the same scale of measurement; or 
standardized mean difference if the studies reported the same out-
come with different measures or scales. For dichotomous variables, 
we used the Mantel-Haenszel method for the risk ratios with 95% 
CI. All tests were two-sided, and P-values < .05 were considered 
statistically significant.
Subgroup analyses were based on standardized mean differ-
ences in systolic blood pressure as it was the most commonly re-
ported outcome measure. Kendall's rank correlation coefficient 
(Kendall's tau) was used to quantify the associations between study 
characteristics and standardized mean differences and completion 
rates, respectively.
4  | RESULTS
We identified 10 052 records through database searches and ad-
ditionally 42 through citations in previous systematic reviews.7,8,13 
Of the 10 094 records, 4127 were duplicates, 825 were reviews, and 
149 were other publication types (eg guidelines or editorials). The re-
maining 4993 records were screened for eligibility based on title and 
abstract, and 4864 records were excluded. All 129 remaining records 
were full text assessed by JL, MML and TM, and inclusion/exclusion 
TA B L E  2   Content of the interventions
Targets of the intervention
Looking after one's health (16 studies)
Modification of behaviour, such as smoking, alcohol use, diet, or 
adherence to medication24-26,30,31,33,34,36,40,41,43-45,47-49
Physical activity
Counselling in physical activity (8 studies)24,30-32,38,39,41,42
Supervised training (aerobic and strength training) (4 
studies)24,30,31,38
Managing stress & anxiety (5 studies)23,24,30,41,43
Activities of daily living (2 studies)
Planning or training of everyday activities23,48
Knowledge about stroke and health
Knowledge about stroke, risk factors, lifestyle, or medication (21 
studies)20,22-26,29-31,34,36,37,39,41,43-47,49
Increasing cognitive skills, such as motivation and self-management 
(10 studies)21-25,32,33,36,42,44
Specific skills such as goal setting or planning behaviour (7 
studies)23,33,41-44,48
Approaches of the intervention
Communicating knowledge
Written material (4 studies)36,43,45,47
Computer-based patient education (4 studies)29,31,34,49
Patient education/group education (12 
studies)22,24,25,29-31,37,41,44,46,47,49
Counselling
Counselling in health behaviour and behavioural change (20 
studies22,26,27,31,33,38-40,47,49; of which 10 studies used a specific 
technic or theoretical framework21,23,25,32,36,41-43,45,48)
Medication
Nicotine substitution (1 study) 40
Self-monitoring
Monitoring of behaviour, physical activity, blood pressure (4 
studies)22,26,41,42
Evaluation of needs
Evaluation of the participants’ needs (6 studies)20,27,28,37,46,48
Support
Professional support (22 studies)20-23,25,27,28,32,33,36-48
Peer support from other patients (4 studies)22-24,38
Social support from family, friends or relatives (6 
studies)20,37,41,43,46,48
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was based on agreement between all three authors. Ultimately, 29 
studies were included in the review (Figure 1 and Table 1).
4.1 | Description of the studies
4.1.1 | Targets of the intervention
Table 2 provides an overview of study rationales and contents of the 
interventions. In 16 studies, the aim was to enable the participants 
to take care of their own health, for example facilitate modification 
of lifestyle factors or adherence to preventive medication. In eight 
studies, the primary aim was to increase the participants’ level of 
physical activity, and in additionally four studies physical activity 
was a minor part of the counselling. Four studies included super-
vised strength and aerobic exercise. Studies including physical activ-
ity also included other elements, such as patient education or health 
counselling (Table 2).
Counselling on anxiety or stress management was included in 
five studies, and two studies included counselling on participation 
in everyday life. Twenty-one studies aimed at providing participants 
with knowledge on their disease, lifestyle and vascular risk factors, 
or preventive medication. Nine studies aimed at providing partici-
pants with the cognitive skills and know how to modify their health 
behaviour, such as motivation, self-efficacy or self-management 
skills, while seven studies aimed at providing specific behavioural 
skills, such as self-monitoring, goal setting and planning behavioural 
change.
4.1.2 | Approaches of the interventions
Of the 21 studies, which included communication of knowledge, 
twelve included direct patient education, of which two were pro-
vided in a group setting. Four studies employed written educa-
tional material and four employed computer-based education. 
Patient counselling was part of the invention in twenty of the 
studies, and in ten of them, the counselling was based in a spe-
cific technic or theoretical framework. Most of them employed 
face-to-face counselling the first time, while the following ses-
sions were provided either face-to-face or by telephone. Only one 
study provided nicotine substitution as a medical aid for smoking 
cessation.
Four studies used self-monitoring; either of physical activity, be-
haviour or blood pressure as a part of the intervention. Additionally, 
six studies had a regular assessment of the participants need for as-
sistance or help.
Systematic support in relation to behavioural change or handling 
own health was a part of the intervention in 23 of the studies. In 22 
of the studies, the support was provided by health professionals 
affiliated with the intervention team, in some cases in addition to 
other types of support, and in a single study, the support was pro-
vided by the participants’ primary physician. Four studies employed 
group elements or activities to facilitate peer support from other 
participants, and in six studies, the participants’ own social network 
was used as support, either by directly including the relatives in ac-
tivities or by encouraging participants to seek support from friends 
and relatives.
In nine studies, the intervention or part of the intervention com-
prised changes to the organization of the care, for example home 
visits, implementation of clinical guidelines, or changes in the com-
munication or collaboration between the hospital and the primary 
physicians.
4.1.3 | Time of recruitment and length of 
intervention
In eight studies, participants were recruited before hospital dis-
charge; in ten studies, they were recruited within the first month; 
and in seven studies, they were recruited between 1-12 months after 
admission. In four studies, the time of recruitment was not reported 
(Table 3).
The length of the interventions varied between three weeks 
and two years, with seven studies in each interval of 3-12 weeks, 
12-13 weeks, 13-52 weeks and ≥ 52 weeks. One study did not report 
the length of the intervention (Table 3).
4.2 | Risk of bias in included studies
Random allocation of participants was an inclusion criterium in this 
review, and all studies therefore stated that they were RCTs. In 25 of 
the studies, the method of randomization was clearly reported, but 
in three studies this was unclear, and in one study, the method was 
not adequately described. In 19 studies, measures to conceal future 
allocations were clearly stated; in nine studies, it was unclear, and in 
one study, measures were inadequate. None of the studies had ad-
equate blinding of participants and personal delivering the interven-
tion; although one study used “placebo” counselling, it was unclear 
if this blinding was effective as the personnel was not blinded. In 13 
studies, the outcome assessments were adequately blinded, but in 
the remaining studies outcome measurements were performed by 
unblinded study personal. In 22 of the studies outcome, data were 
either complete or the incompleteness was clearly accounted for. 
In four studies, the completeness of data was unclear, and in three 
studies, outcome data were clearly missing and not adequately ac-
counted for. In 24 of the studies, results of all outcome measures 
were clearly reported; in four studies, the results were not clearly 
reported in the secondary outcomes measures, and in one study, the 
results were reported in an ambiguous and unclear manner. Other 
potential biases were found: Five studies had baseline imbalances of 
     |  307LILJEHULT ET aL.
potential clinical importance; two studies were stopped early with-
out a clear reason stated; and several studies used block randomi-
zation with fixed block sizes potentially resulting in study personal 
being able to foresee the allocation of some participants before re-
cruitment (Figure 2).
4.3 | Effects of interventions
The most frequent outcome reported were systolic and diastolic 
blood pressure, which were both significantly lower among par-
ticipants in the interventions (Tables 4 and 5, Figure 3). Six stud-
ies reported the number of participants with a systolic blood 
pressure < 140 mmHg at follow-up. In a random effects model, 
the pooled risk ratio was 1.14 (95%CI 1.03-1.25), equivalent to a 
number needed to benefit of 13.83 (95%CI 8.25-42.84) (Table 5, 
Figure 3).
Sub-analyses of the studies reporting systolic blood pressure 
showed that both interventions with and without supervised phys-
ical training had a significant effect, but the effect was greater in 
interventions including supervised training (9.4 (95%CI 3.1-16.6) vs. 
2.6 (95%CI 1.0-4.3) mmHg). The inter-strata differences were not 
significant for time of recruitment, length of the intervention, inter-
vention based on a specific theoretical framework or family support 
(Table 5).
4.4 | Feasibility
The number of potential participants screened for eligibility was 
reported in 20 studies; of 16,227 screened, 3545 were included 
for participation. The inclusion rates ranged from 3.8%-69.3% with 
a weighted mean of 22% (95%CI 21.2-22.5). The rate of inclusion 
from the number of patients eligible for participation was reported 
in eight studies; out of 1448 eligible patients, 836 were included 
for participation. Inclusion rates ranged from 37.3%-88.3% with 
a weighted mean of 58% (95%CI 55.2-60.3). Completion rates of 
participants were reported in 28 studies. Of 8254 participants ran-
domized, 7173 were retained until the final follow-up. Completion 
rates ranged from 49.8%-100% with a weighted mean of 86.9% 
(95%CI 86.2-87.6). Five studies achieved a completion rate of 100% 
(Table 1).
There was a significant correlation between completion rate 
and the timing of recruitment (tau = 0.377; P = .018), an indication 
of a more complete follow-up in studies with late recruitment. No 
significant correlation was found between completion rate and the 
length of the intervention (Kendall's tau = −0.07; P = .63) or time of 
follow-up (Kendall's tau = −0.08; P = .59), respectively.
F I G U R E  2   Risk of bias summary: the authors' judge-ments 
about each risk of bias item for each included study
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5  | DISCUSSION
In this systematic review, we have explored the effects of health be-
haviour counselling and behavioural modification in patients with cere-
brovascular diseases, and potential mediators of the effects. We found 
that, although the effect sizes are modest, supportive behavioural 
interventions might have some additional effect on systolic and dias-
tolic blood pressure, the prevalence of hypertension and low-density 
lipoprotein in the blood compared to usual care. Including supervised 
exercise as part of the intervention seems to enhance the effect on 
systolic blood pressure. Besides that, we did not find any intervention 
elements capable of mediating the effectiveness.
Interventions were applied as add-on to usual care though the 
exact definitions and components of usual care seldom were elu-
cidated. Consequently, we are not able to determine the causal 
mechanism and effects related to the intervention as the effect on, 
for example systolic blood pressure might have been mediated by 
enhanced adherence to medication rather than an isolated interven-
tional effect.
We identified a range of different intervention element, which 
might all contribute to the overall effect of the interventions, but 
only blood pressure and total blood cholesterol were reported 
in ≥ 10 studies, and the lack of uniformly reported outcomes made it 
difficult to compare the effectiveness of the elements.
The inclusion and completion rates varied considerably be-
tween studies. Approximately half of eligible patients consented 
to participation, and the rate of successful follow-up ranged from 
50%-100%. We found some association between the timing of re-
cruitment and the completion rates, implying that participants are 
more likely to leave the study if they are recruited early. A reason 
for this might be that studies with late recruitment primarily ap-
proached patients in outpatient clinics, hence including patients 
who are more motivated to participate in additional treatment, 
if offered. In contrast, the time of recruitment did not seem to 
impact the effect of the intervention. Recruiting participants at 
an early stage is therefore feasible, but a higher rate of attrition 
should be expected.
Previous systematic reviews of behavioural interventions in pa-
tients with stroke have arrived at different conclusions. Deijle et al8 
found an effect on systolic blood pressure; Lawrence et al7 found 
an effect on waist circumference, compliance to preventive med-
ication, anxiety, cardiac events, and systolic and diastolic blood 
pressure, while Bridgwood et al6 found no effect of behavioural 
interventions, but minor effects on TIA recurrence and cardiovas-
cular risk scores in organizational changes. Different statistical ap-
proaches might explain the varying results: Lawrence et al used 
fixed effect models, assuming that “all studies were functionally 
identical,” whereas Bridgwood et al used random effects models 
and Deijle et al different models depending on the degree of het-
erogeneity. We used random effects models in all our meta-analy-
ses, assuming that clinical diversity in study populations, settings 
and interventions contributed to variation between studies,12 and 
therefore, we did not find the assumptions of a fixed effect model 
to be justified.
In a systematic review of qualitative interviews with partici-
pants in secondary stroke prevention interventions and their 
family members, Lawrence et al14 found that the participants 
experienced the interventions as meaningful. The informants 
highlighted the importance of support from health profession-
als, family and other stroke survivors, and that the interventions 
helped them acquire the knowledge and confidence needed to 
change behaviour.
Several interventions incorporated formal support from health 
professionals and informal support from peers and the partici-
pants’ family and social network; patient education or other means 
of communicating knowledge; or counselling in goal setting, 
TA B L E  4   Outcomes reported in each study as either primary, secondary, or part of a compound outcome measure
Adie 
2010
Allen 
2002
Allen 
2009
Barker-
Collo 
2015
Boss 
2014
Boysen 
2009
Brunner 
Frandsen 
2012
Chanruengvanich 
2006
Cheng 
2018
Damush 
2011
English 
2016
Evans- 
Hudnall  
2014
Faulkner  
2014
Flemming 
2013
Gillham 
2010
Holzemer 
2011
Hornnes 
2009
Irewall 
2015
Joubert 
2006
Joubert 
2009
Kim 
2013
Kirk 
2014
Kono 
2013
McManus 
2009
Moren 
2016
Nir 
2004
Peng 
2014
Wan 
2016
Wolfe 
2010
Vital signs 1 1 2 2 1 1 2 2 1 1 2 1 2 2 2
Biochemistry 2 1 2 2 2 2 2 2 2 2 2 2 2 2 2
Body 
composition
2 2 2 2 2 2
Adverse events c c 1 2 1 1 2 2
Function 2 c c 2 1 2 2 2 2
Medication 
adherence
2 2 2 c 2 2 2 2 2 2
Patient 
activation
2 c 2 1 2 2 2 2 2 2
PROM 2 c c 2 2 1 2 2 2 2 2 2 2 2
Risk factors c c 2 1 2 2 1 1 2 1 2 2 2 2 1 2 1 2 1 1 1
Physical activity 2 1 2 2 1
Note: 1: Primary outcome, 2: secondary/tertiary outcomes, c: part of a composite outcome, PROM Patient Reported Outcome Measure.
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planning and confidence to change behaviour. Although the for-
mal effects of the behavioural interventions might be vague, they 
could be meaningful and beneficial to the patients. Cognitive 
difficulties and fatigue are prevalent, even among patients with 
minor stroke15 and for some having a stroke can be a considerable 
change in their life.16
Health behaviour is regulated by a multitude of biological, psy-
chological and social factors.17 Interventions to modify patient be-
haviour are therefore complex in nature. At this point, we are not 
able to recommend any specific approach to behavioural modifica-
tion. The evidence supports that the interventions should include 
physical exercise. Previous research indicates that behavioural inter-
ventions should address several domains8 and have multiple points 
of follow-up over at least a month.8,18
Several potential biases were identified in the included studies. 
All included studies were randomized, and most of them reported the 
procedure of randomization and measures to conceal the allocation 
of future participants. Blinding measure such as assessor blinding 
was only reported in less than half of the studies. Furthermore, the 
use of self-reported outcome measures might be sensitive to rapport 
between the participant and the assessor.
In five studies, the results were reported in an inadequate manner: 
one study only reported results from a model adjusted for baseline 
imbalances. The remaining four lacked necessary details, for exam-
ple. standard deviations, confidence intervals or exact p-values. Such 
inaccuracies made it difficult to assess the risk of selective reporting.
To assess the risk of publication bias, we attempted to match pre-
liminary reports to subsequent full-text publications. We identified 
23 conference proceedings, 18 study protocols and one academic 
thesis that were potentially relevant. Of these records, 10 did not 
fulfil all inclusion criteria and 20 were matched to publications al-
ready included in the search results. Of the remaining 12 reports, we 
managed to find trial registrations on 10 studies. This might indicate 
that there is a risk of publication bias, although this was less than 
observed in other research areas.19
Generalizability of the results might be limited by selection bias. 
The number of patients screened for eligibility was reported in 19 
studies, and the number of eligible patients was reported in nine 
studies (Table 1). The number of refusals was reported in 15 stud-
ies20-34 with proportions ranging from 0.6%-66.7% (median 36.8%). 
Only two studies25,30 reported reasons for refusal (eg lack of time, 
work commitments, transportation problems, lack of interest).
Although this review was designed to be comprehensive, there is 
still a risk that relevant research was not included. We searched sev-
eral different medical databases and searched references of previous 
studies, and we attempted to find full publications of preliminary re-
ports. Due to language restrains, we could only include literature in 
English and Scandinavian languages. We only included study results as 
they were reported in the full-text articles or supplementary material-
supplementary material. But we did not attempt to obtain the original 
datasets or any missing data.
6  | CONCLUSIONS
Interventions to modify health behaviour in patients with stroke and 
prevent stroke recurrence might have a modest effect; but may still 
be meaningful to the patient. Recruiting patients at an early stage 
after stroke does not seem to affect the effect, but a higher attri-
tion rate should be expected. Supervised exercise most likely en-
hances the effect of the interventions on blood pressure. However, 
we need further research on how other approaches, including health 
counselling, support from professionals, relatives, or peers, patient 
education, monitoring of behaviour and health status, and primary 
and secondary sector collaboration, could benefit the patients and 
their relatives.
TA B L E  4   Outcomes reported in each study as either primary, secondary, or part of a compound outcome measure
Adie 
2010
Allen 
2002
Allen 
2009
Barker-
Collo 
2015
Boss 
2014
Boysen 
2009
Brunner 
Frandsen 
2012
Chanruengvanich 
2006
Cheng 
2018
Damush 
2011
English 
2016
Evans- 
Hudnall  
2014
Faulkner  
2014
Flemming 
2013
Gillham 
2010
Holzemer 
2011
Hornnes 
2009
Irewall 
2015
Joubert 
2006
Joubert 
2009
Kim 
2013
Kirk 
2014
Kono 
2013
McManus 
2009
Moren 
2016
Nir 
2004
Peng 
2014
Wan 
2016
Wolfe 
2010
Vital signs 1 1 2 2 1 1 2 2 1 1 2 1 2 2 2
Biochemistry 2 1 2 2 2 2 2 2 2 2 2 2 2 2 2
Body 
composition
2 2 2 2 2 2
Adverse events c c 1 2 1 1 2 2
Function 2 c c 2 1 2 2 2 2
Medication 
adherence
2 2 2 c 2 2 2 2 2 2
Patient 
activation
2 c 2 1 2 2 2 2 2 2
PROM 2 c c 2 2 1 2 2 2 2 2 2 2 2
Risk factors c c 2 1 2 2 1 1 2 1 2 2 2 2 1 2 1 2 1 1 1
Physical activity 2 1 2 2 1
Note: 1: Primary outcome, 2: secondary/tertiary outcomes, c: part of a composite outcome, PROM Patient Reported Outcome Measure.
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TA B L E  5   Results of the meta-analyses
Outcomes Studies Participants Effect Estimate P-value I2 Quality of evidence (GRADE)
Vital signs
Systolic blood pressure 
(mmHg)21,22,24,26-28,30,31,36,38,41,45-47
14 2222 MD −3.85 [−6.43, −1.28] .003** 53% ⊕⊕◯◯ LowA, B
Diastolic blood pressure 
(mmHg)21,24,26,27,30,31,36,38,41,45-47
12 1711 MD −1.60 [−3.09, −0.11] .04* 40% ⊕⊕◯◯ LowA, B
SBP < 140 mmHg22,27,28,37,38,46 6 1546 RR 1.14 [1.03, 1.25] .01** 23% ⊕⊕◯◯ LowA, B
Heart rate (Beats per minute)24,41 2 113 MD −2.87 [−6.34, 0.61] .11 0% ⊕◯◯◯ Very lowA, B, C
Biochemistry
Total cholesterol21,24,28-30,36,41,45-47 10 925 MD −4.25 [−9.27, 1.22] .13 9% ⊕⊕◯◯ LowA, B
HDL21,24,30,31,41,45 6 552 MD 1.64 [−1.12, 4.40] .24 0% ⊕⊕◯◯ LowA, B
LDL22,27,31,38,45 5 1003 SMD −0.23 [−0.41, −0.05] .01** 36% ⊕⊕◯◯ LowA, B
Triglycerides29,45 2 63 MD −14.71 [−43.07, 13.56] .31 0% ⊕◯◯◯ Very lowA, B, C
Fasting blood glucose24,30 2 75 MD −0.19 [−0.47, 0.10] .20 0% ⊕◯◯◯ Very lowA, B, C
HbA1c31,47 2 170 MD 0.12 [−0.46, 0.70] .69 63% ⊕◯◯◯ Very lowA, B, C
TC/HDL-ratio24,30 2 75 MD 0.0 [−0.49, 0.49] .99 0% ⊕◯◯◯ Very lowA, B, C
Body composition
Body mass index24,30,31,46 4 329 MD −0.44 [−1.38, 0.51] .37 0% ⊕◯◯◯ Very lowA, B, C
Body weight 24,31,36,44 4 175 MD −0.53 [−4.09, 3.03] .77 0% ⊕◯◯◯ Very lowA, B, C
Waist-hip ratio24,30 2 75 MD 0.0 [−0.04, 0.03] .83 0% ⊕◯◯◯ Very lowA, B, C
Adverse events
Death (All causes)20,24,37,39,49 5 4668 RR 0.97 [0.58, 1.61] .37 0% ⊕⊕◯◯ LowA, B
Recurrent stroke/TIA20,39,47,49 4 4330 RR 1.08 [0.78, 1.50] .77 0% ⊕⊕◯◯ LowA, B
Adverse events (All)20,31,37,39,42,47,49 7 4813 RR 0.77 [0.56, 1.08] .83 0% ⊕⊕◯◯ LowA, B
Functional level
Modified Rankin scale33,36,39,46 4 606 SMD −0.26 [−0.58, 0.05] .11 69% ⊕◯◯◯ Very lowA, B, C
Patient reported outcomes
Quality of life21,23,30,46,47 6 1546 SMD −0.09 [−0.53, 0.34] .67 85% ⊕◯◯◯ Very lowA, B, D
Sub-analyses Studies Participants Effect Estimate P-value†  I2 References
Time of recruitment 11 1777 SBP (mmHg) .19 40% ⊕⊕◯◯ LowA, B
Early recruitment31,38,45,46 4 303 MD −0.54 [−0.98, −0.10]
1-4 wk21,24,27,30,36 5 968 MD −0.16 [−0.31, −0.00]
Late recruitment22,47 2 506 MD −0.03 [−0.40, 0.33]
Length of the intervention 13 2142 SBP (mmHg) .99 0% ⊕⊕◯◯ LowA, B
3-12 wk24,30,38,41,45 5 193 MD −0.21 [−0.55, 0.13]
13-51 wk21,26,31,36,47 5 875 MD −0.19 [−0.51, 0.12]
≥52 wk22,27,46 3 1074 MD −0.21 [−0.33, −0.09]
Training interventions 13 2142 SBP (mmHg) .04* 76% ⊕⊕◯◯ LowA, B
Training24,30,31,38 4 174 MD −9.83 [−16.56, −3.09]
No training21,22,26,27,36,41,45-47 9 1968 MD −2.61 [−4.26, −0.96]
Theory-based intervention 13 2142 SBP (mmHg) .71 0% ⊕⊕◯◯ LowA, B
Theory based21,22,24,36,38,41,45 7 973 MD −3.99 [−6.36, −1.61]
Non-theory based26,27,30,31,46,47 6 1169 MD −3.35 [−5.67, −1.03]
Family support 13 2142 SBP (mmHg) .74 0% ⊕⊕◯◯ LowA, B
Family/relative support41,46 2 248 MD −2.44 [−11.26, 6.38]
No family support21,22,24,26,27,30,31,36,38,45,47 11 1894 MD −4.00 [−6.91, −1.10]
Note: All meta-analyses are based on random effects models. Mean difference (MD) was used for parametrical outcomes when all studies reported 
the same unit; standardized mean difference (SMD) was used for parametrical outcomes when different units were reported; risk ratio (RR) was used 
for binominal outcome measures.
Abbreviations: HDL, High-density Lipoprotein; LDL, Low-density lipoprotein; MD, Mean difference; RR, Risk ratio; SBP, Systolic blood pressure; 
SMD, Standardized Mean Difference; TC/HDL ratio, Total cholesterol/HDL ratio.
*P < .05, 
**P < .01, 
†P-value for the overall effect of the model. GRADE [50]: A, Down-graded due to insufficient blinding, B, Down-graded due to indirectness caused by 
substantial different intervention, C, Down-graded because the analysis is based on limited data (few studies or few participants), D, Down-graded 
due to the use of indirect outcome measures. 
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F I G U R E  3   Forest plots (Only statistically significant analyses are shown)
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